Email Updates

Search form

You are here

HIV Vaccine

There is momentum and promise in the search for an HIV vaccine.

An effective preventive HIV vaccine would teach the body how to prevent HIV infection. Vaccines are the most powerful public health tools available—and an HIV vaccine would play a powerful role in ensuring the end to the AIDS epidemic.

While effective vaccines remain years away, there are more reasons for hope than ever before. Researchers are expanding on the result of a 2009 trial that showed, for the first time, that a vaccine can reduce the risk of HIV infection. They’re also pursuing groundbreaking research with other novel vaccine strategies, including broadly neutralizing antibodies that target a wide range of HIV strains. At the same time, there is also exciting work in efforts to understand if and how to cure HIV in people who are already infected. The timeline for this work is long and uncertain. Here, too, advocacy is needed to sustain momentum.

Today’s momentum depends on sustained funding. Policy makers and funders around the world must have the courage to sustain vital HIV vaccine research for years to come, and advocates must keep the pressure on them to maintain their commitments.

What We're Reading

The new issue of Current Opinion in HIV and AIDS provides a compelling round-up of literature looking at both the history of vaccine research and what’s ahead in the field.

November 1, 2016
Current Opinion in HIV and AIDS

Kathleen MacQueen, Senior Scientist at FHI 360, and Mitchell Warren, Executive Director of AVAC, strongly advocate for the continued investment of resources into HIV vaccine research.

May 18, 2016
Journal of the International AIDS Society
Subscribe to RSS - HIV Vaccine